$-0.10 EPS Expected for ContraFect (CFRX); Equity Lifestyle Properties (ELS)’s Sentiment Is 1.16

March 15, 2018 - By Winifred Garcia

Analysts expect ContraFect Corporation (NASDAQ:CFRX) to report $-0.10 EPS on March, 21.They anticipate $0.05 EPS change or 33.33% from last quarter’s $-0.15 EPS. After having $0.04 EPS previously, ContraFect Corporation’s analysts see -350.00% EPS growth. The stock increased 0.51% or $0.01 during the last trading session, reaching $1.99. About 199,865 shares traded. ContraFect Corporation (NASDAQ:CFRX) has declined 42.92% since March 15, 2017 and is downtrending. It has underperformed by 59.62% the S&P500.

Equity LifeStyle Properties, Inc. is a publicly owned real estate investment trust . The company has market cap of $8.10 billion. The firm engages in the ownership and operation of lifestyle oriented properties. It has a 39.47 P/E ratio. The Company’s portfolio of properties include various amenities and common facilities, such as a clubhouse, a swimming pool, laundry facilities, and cable television service, sauna/whirlpool spas, golf courses, tennis, shuffleboard and basketball courts, and exercise rooms.

ContraFect Corporation, a clinical-stage biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases in the United States. The company has market cap of $146.58 million. The Company’s lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; and CF-404, a combination of human monoclonal antibodies for the treatment of life-threatening seasonal and pandemic varieties of human influenza. It currently has negative earnings. The firm has a collaboration research agreement with The Rockefeller University to identify new lysin therapeutic candidates targeting Gram-negative bacteria; and license agreement with Trellis Bioscience LLC for mAbs in the field of influenza.

Among 3 analysts covering ContraFect (NASDAQ:CFRX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. ContraFect had 5 analyst reports since December 31, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, December 31 by Maxim Group. The firm earned “Outperform” rating on Wednesday, September 28 by William Blair. The firm has “Buy” rating given on Friday, July 22 by Maxim Group. Roth Capital downgraded ContraFect Corporation (NASDAQ:CFRX) rating on Tuesday, May 10. Roth Capital has “Neutral” rating and $3.30 target.

The stock increased 0.07% or $0.06 during the last trading session, reaching $85.64. About 401,643 shares traded. Equity LifeStyle Properties, Inc. (ELS) has risen 15.90% since March 15, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Resolution Capital Ltd holds 4.36% of its portfolio in Equity LifeStyle Properties, Inc. for 1.11 million shares. American Assets Capital Advisers owns 78,800 shares or 2.63% of their US portfolio. Moreover, Capital Growth Management Lp has 1.86% invested in the company for 500,000 shares. The Ontario – Canada-based Independent Order Of Foresters has invested 1.61% in the stock. L & S Advisors Inc, a California-based fund reported 99,423 shares.

Analysts await Equity LifeStyle Properties, Inc. (NYSE:ELS) to report earnings on April, 16. They expect $1.04 EPS, up 4.00% or $0.04 from last year’s $1 per share. ELS’s profit will be $98.35 million for 20.59 P/E if the $1.04 EPS becomes a reality. After $0.88 actual EPS reported by Equity LifeStyle Properties, Inc. for the previous quarter, Wall Street now forecasts 18.18% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: